⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19721505 | 1.00 | — | — | |
| SCHEMBL3043435 | 1.00 | — | — | |
| SCHEMBL152308 | 0.93 | — | — | |
| SCHEMBL29138985 | 0.91 | CA1 (0.38) | — | |
| SCHEMBL21179347 | 0.91 | CA1 (0.38) | — | |
| SCHEMBL31316288 | 0.91 | CA1 (0.38) | — | |
| SCHEMBL3156917 | 0.84 | — | — | |
| SCHEMBL5699216 | 0.84 | — | — | |
| SCHEMBL230700 | 0.84 | — | — | |
| SCHEMBL31456451 | 0.80 | ATM (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230310551-A1 | INSULIN RECEPTOR PARTIAL AGONISTS | MERCK SHARP & DOHME LLC (US) | 2023-10-05 | — | — | US | disclosed |
| US-20230174534-A1 | COMPOUNDS USEFUL IN HIV THERAPY | GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) | 2023-06-08 | — | — | US | disclosed |
| US-11013745-B2 | Triazolopyrimidine, triazolopyridine compounds, and the composition thereof for treating PRC2-mediated diseases | SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) | 2021-05-25 | — | — | US | disclosed |
| US-20200261459-A1 | TRIAZOLOPYRIMIDINE, TRIAZOLOPYRIDINE COMPOUNDS, AND THE COMPOSITION THEREOF FOR TREATING PRC2-MEDIATED DISEASES | SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) | 2020-08-20 | — | — | US | disclosed |
| CN-110872397-A | Resin composition and resin molded article | 富士施乐株式会社 | 2020-03-10 | — | — | CN | disclosed |
| WO-2020045541-A1 | CHROMATOGRAPHY CARRIER | JSR株式会社 | 2020-03-05 | — | — | WO | disclosed |
| EP-1555261-B1 | VALEROLACTONE COMPOUNDS AND PERFUME COMPOSITION | KAO CORP (JP) | 2010-09-01 | — | — | EP | disclosed |
| US-7491833-B2 | Valerolactone compounds and perfume composition | KAO CORPORATION (JP) | 2009-02-17 | — | — | US | disclosed |
| US-20060258559-A1 | Valerolactone compounds and perfume composition | KAO CORPORATION (JP) | 2006-11-16 | — | — | US | disclosed |
| EP-1555261-A1 | VALEROLACTONE COMPOUNDS AND PERFUME COMPOSITION | Kao Corporation (JP) | 2005-07-20 | — | — | EP | disclosed |
| US-5504219-A | Optically active compounds and intermediates thereof, and process for manufacturing same | ASAHI DENKA KOGYO K.K. (JP) | 1996-04-02 | — | — | US | disclosed |
| US-5352845-A | Process for manufacture of optically active saturated compounds | ASAHI DENKA KOGYO K.K. (JP) | 1994-10-04 | — | — | US | disclosed |
| US-5262552-A | Optically active compounds and intermediates thereof, and process for manufacturing same | ASAHI DENKA KOGYO K.K. (JP) | 1993-11-16 | — | — | US | disclosed |
| US-4690157-A | DERIVATIVES OF BUTYROLACTONE OR VALEROLACTONE; CIGARETTES | PHILIP MORRIS INCORPORATED (US) | 1987-09-01 | — | — | US | disclosed |